Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer. (Q38303667)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Keishi Narita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

Wilma L Lingle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Sally A Mullany

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Julie Staub

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Xiang Qian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Viji Shridhar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

15 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

14413-14420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

The ErbB/HER receptor protein-tyrosine kinases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

HSulf-1 inhibits angiogenesis and tumorigenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Detection of hepatitis C virus RNA in formalin-fixed paraffin-embedded sections with digoxigenin-labeled cRNA probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

The role of amphiregulin in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Overview of tyrosine kinase inhibitors in clinical breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Aromatase inhibitors: combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611395200

21 January 2018

Identifiers

DOI

10.1074/JBC.M611395200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17363371%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference